Context Therapeutics (CNTX) Stock Chart & Stock Price History → The only financial event in 2024 that matters (From Porter & Company) (Ad) Free CNTX Stock Alerts $1.98 -0.02 (-1.00%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Context Therapeutics Stock Price Performance5 Day Performance-2.94%1 Month Performance+13.14%3 Month Performance+72.17%6 Month Performance+109.97%Year-To-Date Performance+75.22%1 Year Performance+54.69% Receive CNTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. CNTX Stock Chart for Sunday, June, 2, 2024 CNTX Chart by TradingView Context Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$2.00$1.98-1.00%$2.03$1.94110,043 shs$148.50 million05/30/2024$2.00$2.00$2.03$1.9867,540 shs$150 million05/29/2024$2.04$2.00-1.96%$2.09$1.9958,724 shs$150 million05/28/2024$2.00$2.04+2.00%$2.12$1.90218,219 shs$153 million05/27/2024$2.00$2.00$2.00$1.88180,200 shs$150 million05/24/2024$1.95$2.00+2.56%$2.00$1.88180,088 shs$150 million Get the Latest News and Ratings for CNTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$1.95$1.95$2.00$1.87134,304 shs$146.25 million05/22/2024$2.03$1.95-3.94%$2.05$1.90113,044 shs$146.25 million05/21/2024$1.99$2.03+2.01%$2.04$1.92148,328 shs$152.25 million05/20/2024$2.00$1.99-0.50%$2.06$1.83224,889 shs$149.25 million05/17/2024$1.80$2.00+11.11%$2.10$1.78616,450 shs$150.00 million05/16/2024$1.69$1.80+6.51%$1.86$1.68817,187 shs$135 million05/15/2024$1.71$1.69-1.17%$1.79$1.66231,656 shs$126.75 million05/14/2024$1.68$1.71+1.79%$1.74$1.63101,327 shs$128.25 million05/13/2024$1.87$1.68-10.16%$1.89$1.65255,437 shs$126 million05/10/2024$1.83$1.87+2.19%$1.95$1.76176,997 shs$0.0005/09/2024$1.81$1.83+1.10%$2.01$1.76598,476 shs$0.0005/08/2024$1.72$1.81+5.23%$1.85$1.68111,786 shs$0.0005/07/2024$1.78$1.72-3.37%$1.85$1.53738,110 shs$0.0005/06/2024$1.85$1.78-3.78%$1.83$1.70366,109 shs$0.0005/03/2024$1.75$1.85+5.71%$1.88$1.661.20 million shs$0.0005/02/2024$1.38$1.75+27.27%$1.88$1.3626.47 million shs$0.0005/01/2024$1.33$1.38+3.38%$1.39$1.3137,162 shs$0.0004/30/2024$1.37$1.33-2.92%$1.36$1.3133,913 shs$0.0004/29/2024$1.41$1.37-2.84%$1.44$1.3120,173 shs$0.0004/26/2024$1.38$1.41+2.18%$1.45$1.3719,984 shs$0.0004/25/2024$1.30$1.38+6.15%$1.38$1.3227,159 shs$0.0004/24/2024$1.41$1.30-7.80%$1.44$1.3036,608 shs$0.0004/23/2024$1.36$1.41+3.68%$1.48$1.3823,977 shs$0.0004/22/2024$1.32$1.36+3.03%$1.39$1.3013,903 shs$0.0004/19/2024$1.37$1.32-3.65%$1.45$1.325,702 shs$0.0004/18/2024$1.39$1.37-1.44%$1.50$1.3745,929 shs$0.0004/17/2024$1.46$1.39-4.79%$1.52$1.3733,798 shs$0.0004/16/2024$1.51$1.46-3.31%$1.58$1.4336,225 shs$0.0004/15/2024$1.49$1.51+1.34%$1.58$1.4534,979 shs$0.0004/12/2024$1.52$1.49-1.97%$1.58$1.42115,081 shs$0.0004/11/2024$1.35$1.52+12.59%$1.60$1.34179,371 shs$0.0004/10/2024$1.31$1.35+3.05%$1.38$1.3042,542 shs$0.0004/09/2024$1.30$1.31+0.77%$1.34$1.2726,465 shs$0.0004/08/2024$1.27$1.30+2.36%$1.47$1.2835,358 shs$20.76 millionThe Worst is Yet to Come… (Ad)Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now.04/05/2024$1.28$1.27-0.78%$1.36$1.269,865 shs$0.0004/04/2024$1.24$1.28+3.23%$1.30$1.2312,899 shs$20.44 million04/03/2024$1.36$1.24-8.82%$1.40$1.2460,604 shs$0.0004/02/2024$1.37$1.36-0.73%$1.40$1.3061,235 shs$22.03 million04/01/2024$1.38$1.37-0.72%$1.57$1.31488,239 shs$22.03 million03/29/2024$1.38$1.38$1.49$1.3856,044 shs$22.04 million03/28/2024$1.38$1.38$1.49$1.3856,044 shs$20.28 million03/27/2024$1.24$1.38+11.29%$1.47$1.25217,320 shs$20.12 million03/26/2024$1.28$1.24-3.13%$1.30$1.2064,685 shs$18.60 million03/25/2024$1.17$1.28+9.87%$1.30$1.18236,435 shs$18.60 million03/22/2024$1.07$1.17+8.88%$1.18$1.08118,794 shs$18.36 million03/21/2024$1.15$1.07-6.96%$1.24$1.06104,569 shs$17.56 million03/20/2024$1.10$1.15+4.55%$1.18$1.0853,284 shs$17.24 million03/19/2024$1.08$1.10+1.85%$1.16$1.0956,609 shs$17.57 million03/18/2024$1.09$1.08-0.92%$1.14$1.0721,243 shs$17.72 million03/15/2024$1.11$1.09-1.80%$1.12$1.0641,704 shs$18.36 million03/14/2024$1.15$1.11-3.48%$1.17$1.0610,252 shs$17.73 million03/13/2024$1.17$1.15-1.71%$1.18$1.1520,460 shs$19 million03/12/2024$1.19$1.17-1.68%$1.22$1.166,849 shs$19.16 million03/11/2024$1.20$1.19-0.83%$1.24$1.176,138 shs$19.16 million03/08/2024$1.15$1.20+4.35%$1.26$1.13226,094 shs$16.76 million03/07/2024$1.05$1.15+9.52%$1.18$1.1046,887 shs$18.68 million03/06/2024$1.17$1.05-10.26%$1.22$1.03104,240 shs$18.20 million03/05/2024$1.14$1.17+2.63%$1.19$1.0780,374 shs$18.69 million03/04/2024$1.15$1.14-0.87%$1.18$1.0944,920 shs$18.36 million03/01/2024$1.14$1.15+0.88%$1.18$1.1211,261 shs$18.37 million Related Companies: SGMT Stock Price Chart GOSS Stock Price Chart SYRS Stock Price Chart INCR Stock Price Chart CYBN Stock Price Chart CTMX Stock Price Chart RAPT Stock Price Chart RPTX Stock Price Chart RIGL Stock Price Chart IMAB Stock Price Chart Receive CNTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Context Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CNTX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden replacement revealed?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Context Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.